New York State Common Retirement Fund
AVTX icon

New York State Common Retirement Fund’s Avalo Therapeutics AVTX Stock Holding History

New York State Common Retirement Fund’s Portfolio AVTX Stock Details AVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$272K Buy
+14,700
New +$232K ﹤0.01% 2246
2022
Q4 		– Hold
0
– – – 3237
2022
Q3 		– Hold
0
– – – 3277
2022
Q2 		– Sell
-8
Closed -$10.7K – 3473
2022
Q1 		$16K Hold
8
– – ﹤0.01% 3298
2021
Q4 		$38K Hold
8
– – ﹤0.01% 3263
2021
Q3 		$48K Hold
8
– – ﹤0.01% 3246
2021
Q2 		$72K Hold
8
– – ﹤0.01% 3244
2021
Q1 		$66K Buy
8
+7
+700% +$66.1K ﹤0.01% 3160
2020
Q4 		$9K Hold
1
– – ﹤0.01% 3256
2020
Q3 		$8K Hold
1
– – ﹤0.01% 3218
2020
Q2 		$9K Hold
1
– – ﹤0.01% 3200
2020
Q1 		$8K Sell
1
-7
-88% -$74K ﹤0.01% 3153
2019
Q4 		$118K Hold
8
– – ﹤0.01% 2958
2019
Q3 		$72K Hold
8
– – ﹤0.01% 3106
2019
Q2 		$119K Buy
+8
New +$121K ﹤0.01% 3040

Other funds holding AVTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

New York State Common Retirement Fund's AVTX Position: Q2 2026 in Review

New York State Common Retirement Fund opened a new position in Avalo Therapeutics (AVTX) in Q2 2026: 14,700 shares worth $272K. The stake represents ﹤0.01% of the portfolio and ranks #2246 among its holdings. This is a return to the name: New York State Common Retirement Fund previously reported a position in AVTX as recently as Q1 2022.

New York State Common Retirement Fund first reported a position in AVTX in Q2 2019 and has held it in 13 quarters since. 126 funds tracked by Wall St. Rank hold AVTX as of Q2 2026.

  • New York State Common Retirement Fund held 14,700 shares of Avalo Therapeutics worth $272K as of Q2 2026.
  • Avalo Therapeutics was a new New York State Common Retirement Fund position in Q2 2026.
  • Avalo Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2246 holding.
  • New York State Common Retirement Fund first reported a position in Avalo Therapeutics in Q2 2019 and has held it in 13 quarters since.
  • 126 funds tracked by Wall St. Rank held Avalo Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.